Medical & Commercial
Drug Intelligence is your strategic partner through the lifecycle of your therapeutic product and portfolio
Epidemiology, patient & treatment flow, competitive landscape, specialist level data accurate market forecast assumptions.
Real-World longitudinal data for gap analysis, payer awareness and submissions.
Assess the gaps and understand actual clinical experience on existing treatments.
Post-approval early uptake monitoring and payer detail in target patient segments.
Quarterly reporting of class & products by indication and line of treatment
Drivers for Uptake
Clinical and other factors impacting early adoption
Quarterly tracking of patient or product share and competitor activity.
Identify patient characteristics and clinical gaps that are creating barriers to growth.
Reflect real-world, real-practice product experience.